查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2005120

支台齿植入市场：依材料、产品类型、最终用户、连接方式及通路划分－2026-2032年全球市场预测

Abutment Implants Market by Material, Product Type, End User, Connection Type, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年支台齿植入市场价值为 5.5118 亿美元，预计到 2026 年将成长至 5.9218 亿美元，复合年增长率为 6.88%，到 2032 年将达到 8.7824 亿美元。

主要市场统计数据
基准年 2025 5.5118亿美元
预计年份：2026年 5.9218亿美元
预测年份 2032 8.7824亿美元
复合年增长率 (%) 6.88%

对现代支台齿植入市场进行简要概述，重点关注材料和製造技术的创新，以及不断变化的临床和采购重点。

支台齿和植入领域正处于先进生物材料、精密製造和不断发展的临床实践的交汇点。近年来，临床医生和医疗设备製造商之间的合作日益紧密，旨在改善产品的美观、功能性和长期组织反应。同时，设计和製造方面的创新正在缩短前置作业时间，并实现更高程度的客製化。因此，从手术团队到采购负责人，相关人员都在重新评估产品选择标准，优先考虑产品的耐用性、软组织整合性和能够缩短病患反应时间的高效工作流程。

材料的飞跃、数位化製造的采用以及采购管道的演变，正在重新定义产品策略和临床部署路径。

支台齿植入领域正经历一场变革，其驱动力来自材料创新、数位化製造以及不断变化的临床偏好。临床医生越来越倾向于选择能够最大限度地减少软组织併发症并带来可预测美学效果的解决方案，这促使製造商在改进钛合金系统的同时，加大对氧化锆材料的研发投入。这种材料研发的融合反映了整个产业从标准化组件转向根据患者的解剖结构和美学需求量身定制的解决方案的趋势。

本研究检验了美国近期的关税措施如何重塑整个支台齿植入生态系统的采购选择、供应链弹性策略和采购实践。

美国近期关税政策的变化进一步增加了基支台齿植入采购和供应链计算的复杂性。进口关税及相关贸易措施不仅影响接收成本，还会影响采购决策、库存策略和供应商选择标准。进口商和经销商正在透过重新评估供应商所在地、探索近岸外包方案以及协商更清晰地分配贸易风险的合约条款来应对这些变化。

详细的細項分析揭示了材料选择、客製化生产方法、最终用户需求、连接形状和多样化的通路如何影响临床应用和商业策略。

细分市场层面的趋势清楚地展现了整个基植入支台齿市场的需求和创新集中方向。材料差异正在影响产品定位。钛因其悠久的临床应用历史和优异的机械强度而备受青睐，而氧化锆则在註重美观的领域日益普及。氧化锆的演进包括单片氧化锆（适用于特定的高强度应用）和多层氧化锆（在前牙修復中具有更优的光学性能）。这些材料进步正在影响临床医生的建议和修復通讯协定。

区域比较分析显示，美洲、欧洲、中东、非洲和亚太地区在实施模式、监管多样性和采购方法的复杂程度方面存在差异。

区域趋势对策略规划至关重要，因为不同地区的采用模式、法律规范和采购惯例差异显着。在美洲，完善的临床网络、高比例的私人牙科诊所和先进的报销机制，促进了成熟的钛合金系统和新兴的二氧化锆替代方案的快速普及。该地区采购流程的日益精细化，使得整合服务交付和增值技术支援成为主流，从而影响了供应商的选择，而不仅限于价格比较。

竞争情报概述揭示了成熟企业和敏捷的新参与企业如何利用临床关係、製造能力和数位伙伴关係来打入市场。

支台齿植入领域的竞争格局呈现出多元化的态势，既有成熟的植入系统供应商，也有专业组件製造商，还有新兴的数位化先锋参与企业。成熟的製造商凭藉着深厚的临床关係、丰富的法规遵循经验和广泛的分销网络，在医疗采购管道中保持着稳固的地位。这些成熟企业通常优先考虑产品改进、供应可靠性和临床教育项目，以维持外科医生和修復科医生的支持。

为协助高阶主管协调产品、製造、分销和临床医生参与策略，以加速产品推广和商业性成功，提供切实可行的优先建议。

产业领导者应优先考虑一系列切实可行的倡议，将技术能力转化为商业性优势。首先，他们应围绕临床差异化的价值提案整合产品系列组合，使其与当地需求和终端使用者的工作流程相契合。这意味着在材料和连接方式的选择上，应显着改善美学和生物学效果，同时清晰地向外科医生和修復团队传达这些优势。

对混合方法研究途径进行透明的解释，该方法整合了对临床医生的访谈、技术文献和监管审查，以产生具有实际意义的见解。

本研究结合了对临床医生、采购负责人和生产专家的访谈，以及对同行评审的临床文献、监管申报文件和产品规格说明的全面审查。这种方法强调三角验证，将临床发现与生产能力和分销实际情况进行交叉检验，以确保结论不仅反映临床需求，也反映营运可行性。

简洁的整合突显了材料、製造、临床检验和商业策略的融合，以此作为实现永续应用和改善病患疗效的途径。

支台齿和植入领域正处于转折点，材料科学、数位化製造和商业策略的融合正在重塑临床实践。钛的可靠性已得到充分验证，而氧化锆因其美观性和软组织修復效果而日益受到关注，这就要求製造商协调这些材料的选择、基台的形状以及修復流程，以确保治疗效果的一致性。虽然数位化製造方法和客製化解决方案正在降低个人化治疗的门槛，但这些进步也需要对品管系统和临床医生培训进行相应的投入。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：支台齿植入市场：依材料分类

  • 钛
  • 氧化锆
    • 整体式氧化锆
    • 多层氧化锆

第九章：支台齿植入市场：依产品类型划分

  • 风俗
    • 3D列印
    • CAD/CAM
  • 库存

第十章：基台植入市场：依最终用户支台齿

  • 牙医诊所
  • 医院
  • 专科诊所

第十一章 依连接类型支台齿植入市场

  • 球形连接器
  • 外六边形
  • 内六角形

第十二章：支台齿植入市场：依通路划分

  • 离线
  • 在线的

第十三章：基台植入市场：依地区支台齿

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：支台齿植入市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：基台植入市场：依国家支台齿

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国支台齿植入市场

第十七章：中国支台齿植入市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ACE Surgical Supply Co
  • ADIN Dental Implant Systems Ltd
  • Bicon LLC
  • BioHorizons Inc
  • Camlog Biotechnologies AG
  • Cortex Dental Implants Industries Ltd
  • Dentium Co Ltd
  • Dentsply Sirona Inc
  • DIO Implant Co Ltd
  • Envista Holdings Corporation
  • Glidewell Laboratories
  • Henry Schein Inc
  • Ivoclar Vivadent AG
  • Keystone Dental Inc
  • MegaGen Implant Co Ltd
  • MIS Implants Technologies Ltd
  • Neoss Ltd
  • Nobel Biocare Services AG
  • Osstem Implant Co Ltd
  • Southern Implants
  • Straumann Holding AG
  • Sweden & Martina SpA
  • Thommen Medical AG
  • Zest Anchors LLC
  • ZimVie Inc
Product Code: MRR-B16853776B87

The Abutment Implants Market was valued at USD 551.18 million in 2025 and is projected to grow to USD 592.18 million in 2026, with a CAGR of 6.88%, reaching USD 878.24 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 551.18 million
Estimated Year [2026] USD 592.18 million
Forecast Year [2032] USD 878.24 million
CAGR (%) 6.88%

A concise orientation to the contemporary abutment implant landscape highlighting materials, manufacturing innovations, and shifting clinical and procurement priorities

The abutment implant sector sits at the intersection of advanced biomaterials, precision manufacturing, and evolving clinical practice. Recent years have seen clinicians and device manufacturers collaborate more closely to improve esthetics, functionality, and long-term tissue response, while innovations in design and production are reducing lead times and enabling greater customization. As a result, stakeholders from surgical teams to procurement officers are revisiting product selection criteria to prioritize durability, soft-tissue integration, and streamlined workflows that reduce chair time.

Transitioning from research-driven experimentation to clinically validated solutions has sharpened competitive dynamics. Developers are balancing proven titanium systems with the growing clinical appetite for zirconia alternatives, which promise superior aesthetics for anterior restorations and improved soft tissue outcomes in select patient cohorts. At the same time, advances in digital dentistry-driven by CAD/CAM and additive manufacturing-are reconfiguring supply chains and expanding the range of viable custom solutions. These technological shifts are complemented by evolving reimbursement frameworks and procurement behaviors that favor demonstrable clinical benefits and cost-efficient supply models.

Taken together, the industry is moving toward integrated offerings that combine material science, manufacturing agility, and evidence-based clinical protocols. Decision-makers require concise, actionable intelligence to navigate trade-offs among material choices, connection geometries, and distribution strategies, ensuring that product investments align with both clinician expectations and patient outcomes.

How material breakthroughs, digital manufacturing adoption, and evolving procurement channels are collectively redefining product strategies and clinical adoption pathways

The abutment implant arena is undergoing transformative shifts driven by material innovation, digital manufacturing, and changing clinical preferences. Clinicians are increasingly favoring solutions that deliver predictable esthetic outcomes while minimizing soft-tissue complications, prompting manufacturers to invest in zirconia development alongside improvements in titanium systems. This convergence of material pathways reflects a broader industry move from one-size-fits-all components toward tailored solutions that match patient anatomy and esthetic demands.

Simultaneously, digital workflows are maturing. CAD/CAM systems and additive manufacturing have moved from experimental to operational use in many specialty clinics and dental laboratories, enabling faster turnaround for custom abutments and reducing dependency on centralized production. The ability to produce patient-specific geometries improves prosthetic fit and clinician satisfaction, while also placing pressure on traditional stock product providers to differentiate on speed, cost, or integrated service offerings.

Procurement channels are also evolving. Healthcare buyers and clinic operators are adopting procurement strategies that weigh clinical evidence, total cost of ownership, and supply resilience. Distribution models extend beyond traditional distributors to include direct tender arrangements and e-commerce platforms that streamline ordering and inventory management. These combined shifts require suppliers to be agile across manufacturing, regulatory compliance, and commercial models to maintain clinical relevance and secure long-term adoption.

Examining how recent United States tariff measures are reshaping sourcing choices, supply chain resilience strategies, and procurement behavior across the abutment implant ecosystem

Recent tariff developments in the United States have injected additional complexity into the procurement and supply-chain calculus for abutment implants. Import duties and related trade measures affect not only landed cost but also sourcing decisions, inventory strategies, and supplier selection criteria. Importers and distributors are responding by reassessing supplier footprints, considering nearshoring options, and negotiating contract terms that more explicitly allocate trade-related risk.

Clinicians and institutional buyers are feeling indirect effects through pricing pressures and altered product availability. In some instances, higher landed costs have accelerated conversations about local manufacturing and domestic capacity building, with stakeholders assessing the feasibility of shifting production to regions with favorable trade relationships or closer proximity to end-users. At the same time, manufacturers outside of tariff jurisdictions are leveraging their relative cost advantage to pursue expanded distribution agreements and to strengthen relationships with national distributors.

Operationally, supply chain teams are refining inventory policies to buffer against volatility, increasing visibility across tiered suppliers, and identifying alternative components or materials that maintain clinical performance while reducing exposure to tariff-related cost swings. Regulatory compliance and quality control remain paramount during any sourcing transition, and successful organizations are those that balance cost management with the rigorous clinical and safety standards required for implantable dental components.

In-depth segmentation analysis revealing how material choices, custom production methods, end-user demands, connection geometries, and diverse distribution routes shape clinical adoption and commercial strategy

Segment-level dynamics offer a nuanced view of where demand and innovation are concentrating across the abutment implant space. Material distinctions drive product positioning: titanium continues to be prized for its long-standing clinical performance and mechanical strength, while zirconia is gaining traction where esthetic considerations are paramount. Zirconia's evolution includes both monolithic zirconia options, favored for certain high-strength applications, and multi-layer zirconia variants that offer improved optical properties for anterior restorations; these material pathways are shaping clinician recommendations and restorative protocols.

Product type segmentation differentiates off-the-shelf stock abutments from increasingly popular custom solutions. Custom abutments are being delivered via CAD/CAM workflows and additive manufacturing techniques such as 3D printing, enabling individualized emergence profiles and enhanced soft-tissue management. This capability is particularly valued in complex cases where prosthetic contours and esthetics are critical, whereas stock abutments retain relevance for standardized cases that prioritize cost efficiency and rapid availability.

End users vary in clinical needs and procurement sophistication. Dental clinics frequently pursue solutions that streamline chairside workflows and improve aesthetic outcomes, hospitals emphasize compatibility with broader surgical protocols and inventory management, and specialty clinics prioritize advanced restorative options and bespoke components. Connection type matters clinically and operationally; ball connector systems, external hex, and internal hex interfaces each offer distinct surgical handling characteristics and prosthetic considerations that influence clinician preference and inventory strategy. Finally, distribution channels influence access and purchasing behavior. Direct tender arrangements offer large institutional buyers predictable supply terms, distributors provide breadth of product offerings and local service, and online channels are simplifying ordering for smaller practices and enabling faster replenishment. These segmentation lenses collectively inform product development, commercial targeting, and supply chain design.

Comparative regional intelligence showing how adoption patterns, regulatory diversity, and procurement sophistication differ across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics are central to strategic planning as adoption patterns, regulatory frameworks, and procurement practices vary significantly across geographies. In the Americas, strong clinical networks, high levels of private dental practice penetration, and advanced reimbursement environments support rapid uptake of both established titanium systems and emerging zirconia alternatives. Procurement sophistication in this region often favors integrated service offerings and value-added technical support, influencing vendor selection beyond simple price comparisons.

Across Europe, Middle East & Africa, the regulatory landscape and heterogeneous healthcare systems lead to differentiated adoption curves. Some markets show early enthusiasm for aesthetic-driven zirconia solutions and digitally enabled services, while others rely on traditional titanium-based systems due to entrenched clinical protocols and supply relationships. Distributors play a pivotal role in bridging manufacturer capabilities with diverse clinical settings, and cross-border trade considerations influence sourcing strategies and distribution footprints.

In Asia-Pacific, rapid investment in dental infrastructure, growing middle-class demand for elective dental procedures, and an expanding network of specialty clinics are driving innovation adoption. Manufacturers looking to expand in this region must navigate varied regulatory requirements, local manufacturing expectations, and evolving clinician preferences that increasingly value both aesthetic outcomes and digitally integrated workflows. Each region presents distinct opportunities and constraints, and companies that tailor their product, regulatory, and commercial approaches to regional realities are better positioned to capture clinical adoption and build durable partnerships.

Competitive intelligence overview identifying how incumbents and agile entrants leverage clinical relationships, manufacturing capabilities, and digital partnerships to win adoption

Competitive dynamics in the abutment implant segment reflect a mix of established implant system providers, specialty component manufacturers, and emerging digital-first entrants. Established manufacturers leverage deep clinical relationships, extensive regulatory experience, and broad distribution networks to maintain presence in institutional procurement channels. These incumbents often prioritize incremental product enhancements, supply reliability, and clinical education programs to sustain preference among surgeons and restorative dentists.

Concurrently, smaller and more agile companies are carving niches by focusing on material innovation, customized manufacturing workflows, or digital integration that shortens delivery cycles. These entrants frequently collaborate with dental laboratories and specialty clinics to validate performance and to build clinical case libraries that support adoption. Partnerships between component manufacturers and digital-platform providers are also becoming more common, creating bundled offerings that simplify the transition to CAD/CAM or additive workflows for clinicians who lack in-house digital capabilities.

Across the competitive landscape, firms that combine demonstrable clinical outcomes with flexible manufacturing and responsive distribution tend to win adoption. Strategic investments in regulatory pathways, clinician training, and after-sales technical support are differentiators. The most successful organizations align product development with the practical realities of clinical workflows and procurement processes, ensuring that innovations translate into tangible benefits at the point of care.

Practical, prioritized recommendations for executives to align product, manufacturing, distribution, and clinician engagement strategies to accelerate adoption and commercial success

Industry leaders should prioritize a set of actionable initiatives to convert technical capability into commercial advantage. First, align product portfolios around clinically differentiated value propositions that match regional demands and end-user workflows. This means advancing material and connection decisions that demonstrably improve esthetic and biological outcomes while communicating those benefits clearly to surgeons and restorative teams.

Second, invest in digital and manufacturing flexibility. Expanding CAD/CAM compatibility and selective use of additive manufacturing can reduce lead times for custom abutments and enhance clinician satisfaction. Equally important is the development of robust quality and regulatory processes that permit rapid iteration without compromising safety or compliance.

Third, refine distribution strategies to balance reach with service. A hybrid approach that combines direct tender relationships for large institutional buyers, selective distributor partnerships for market coverage, and targeted online channels for smaller practices can optimize accessibility and control. Finally, strengthen clinician engagement through targeted education, case support, and evidence generation that underscores clinical benefits. By integrating these initiatives, companies can reduce friction in adoption pathways and create sustainable differentiation.

Transparent explanation of the mixed-methods research approach that integrates clinician interviews, technical literature, and regulatory review to produce operationally relevant insights

This research synthesizes primary interviews with clinicians, procurement officers, and manufacturing experts, combined with a careful review of peer-reviewed clinical literature, regulatory filings, and documented product specifications. The approach emphasizes triangulation: clinical insights are cross-validated against manufacturing capabilities and distribution realities to ensure conclusions reflect operational feasibility as well as clinical desirability.

Primary qualitative research involved structured conversations with restorative dentists, oral surgeons, dental lab managers, and supply-chain leaders to understand drivers of product selection, tolerance for new materials, and the practicalities of integrating custom solutions into existing workflows. Secondary sources focused on material science developments, published comparative studies on abutment outcomes, and regulatory guidance that informs product registration and clinical use. Wherever possible, technical claims were corroborated by device documentation and clinical case series to provide a balanced assessment.

Analytical methods prioritize actionable synthesis over broad numerical forecasting. The study highlights practical implications, trade-offs, and decision levers for stakeholders considering product development, market entry, or portfolio optimization, ensuring recommendations are grounded in both clinical practice and commercial realities.

A concise synthesis emphasizing the convergence of materials, manufacturing, clinical validation, and commercial strategy as the pathway to durable adoption and improved patient outcomes

The abutment implant sector stands at an inflection point where material science, digital manufacturing, and commercial strategy converge to reshape clinical practice. Titanium's legacy of reliable performance coexists with growing interest in zirconia for aesthetic and soft-tissue outcomes, and manufacturers must reconcile these material choices with connection geometries and prosthetic workflows to deliver consistent results. Digital production methods and customized solutions are reducing barriers to tailored care, yet these advances require parallel investments in quality systems and clinician education.

Procurement and distribution dynamics are also evolving, with tariff considerations and regional regulatory differences prompting a re-evaluation of sourcing and inventory strategies. Organizations that proactively address supply-chain resilience, while maintaining rigorous clinical validation, will be better positioned to navigate volatility. Ultimately, success favors companies that couple technical excellence with pragmatic commercialization: clear evidence of clinical benefit, responsive manufacturing capabilities, and channel strategies aligned to end-user needs.

Leaders who focus on integrated offerings-materials, manufacturing, clinical support, and distribution-can convert innovation into market adoption and deliver superior patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Abutment Implants Market, by Material

  • 8.1. Titanium
  • 8.2. Zirconia
    • 8.2.1. Monolithic Zirconia
    • 8.2.2. Multi-Layer Zirconia

9. Abutment Implants Market, by Product Type

  • 9.1. Custom
    • 9.1.1. 3D Printed
    • 9.1.2. CAD/CAM
  • 9.2. Stock

10. Abutment Implants Market, by End User

  • 10.1. Dental Clinics
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Abutment Implants Market, by Connection Type

  • 11.1. Ball Connector
  • 11.2. External Hex
  • 11.3. Internal Hex

12. Abutment Implants Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Abutment Implants Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Abutment Implants Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Abutment Implants Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Abutment Implants Market

17. China Abutment Implants Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACE Surgical Supply Co
  • 18.6. ADIN Dental Implant Systems Ltd
  • 18.7. Bicon LLC
  • 18.8. BioHorizons Inc
  • 18.9. Camlog Biotechnologies AG
  • 18.10. Cortex Dental Implants Industries Ltd
  • 18.11. Dentium Co Ltd
  • 18.12. Dentsply Sirona Inc
  • 18.13. DIO Implant Co Ltd
  • 18.14. Envista Holdings Corporation
  • 18.15. Glidewell Laboratories
  • 18.16. Henry Schein Inc
  • 18.17. Ivoclar Vivadent AG
  • 18.18. Keystone Dental Inc
  • 18.19. MegaGen Implant Co Ltd
  • 18.20. MIS Implants Technologies Ltd
  • 18.21. Neoss Ltd
  • 18.22. Nobel Biocare Services AG
  • 18.23. Osstem Implant Co Ltd
  • 18.24. Southern Implants
  • 18.25. Straumann Holding AG
  • 18.26. Sweden & Martina SpA
  • 18.27. Thommen Medical AG
  • 18.28. Zest Anchors LLC
  • 18.29. ZimVie Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ABUTMENT IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ABUTMENT IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MONOLITHIC ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MONOLITHIC ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MONOLITHIC ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MULTI-LAYER ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MULTI-LAYER ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MULTI-LAYER ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY 3D PRINTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY 3D PRINTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY 3D PRINTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CAD/CAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CAD/CAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CAD/CAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY STOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY STOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY STOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY BALL CONNECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY BALL CONNECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY BALL CONNECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY EXTERNAL HEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY EXTERNAL HEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY EXTERNAL HEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY INTERNAL HEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY INTERNAL HEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY INTERNAL HEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)